ES PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ES PHARMA
Largest movements
- Cash +€42,231
up €42,231 (+258%), from €16,344 to €58,575
mainly Net result for the year (+€32,777) and Depreciation (+€6,667)
- Tangible fixed assets -€6,667
down €6,667 (-22.8%), from €29,276 to €22,609
- Receivables within one year -€6,336
down €6,336 (-71.6%), from €8,846 to €2,510
- Reserves +€32,777
up €32,777 (+297%), from €11,043 to €43,820
- Debts after one year -€5,885
down €5,885 (-26.5%), from €22,226 to €16,341
- Other debts +€1,840
up €1,840 (+39.0%), from €4,720 to €6,560
- Gross operating margin +€30,699
up €30,699 (+166%), from €18,464 to €49,163
- Taxes +€5,642
up €5,642 (+197%), from €2,871 to €8,513
- Depreciation +€2,607
up €2,607 (+64.2%), from €4,061 to €6,667
- Financial charges +€597
up €597 (+122%), from €489 to €1,086
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €55,454 | €84,690 | +€29,236 | +52.7% |
| Fixed assets | 21/28 | €29,276 | €22,609 | -€6,667 | -22.8% |
| Tangible fixed assets | 22/27 | €29,276 | €22,609 | -€6,667 | -22.8% |
| Furniture and vehicles | 24 | €29,276 | €22,609 | -€6,667 | -22.8% |
| Current assets | 29/58 | €26,178 | €62,081 | +€35,904 | +137% |
| Amounts receivable within one year | 40/41 | €8,846 | €2,510 | -€6,336 | -71.6% |
| Trade receivables | 40 | €8,846 | €2,510 | -€6,336 | -71.6% |
| Cash at bank and in hand | 54/58 | €16,344 | €58,575 | +€42,231 | +258% |
| Deferred charges and accrued income | 490/1 | €988 | €997 | +€9 | +0.9% |
| Total equity and liabilities | 10/49 | €55,454 | €84,690 | +€29,236 | +52.7% |
| Equity | 10/15 | €14,043 | €46,820 | +€32,777 | +233% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €11,043 | €43,820 | +€32,777 | +297% |
| Distributable reserves | 133 | €11,043 | €43,820 | +€32,777 | +297% |
| Amounts payable | 17/49 | €41,411 | €37,870 | -€3,541 | -8.6% |
| Amounts payable after more than one year | 17 | €22,226 | €16,341 | -€5,885 | -26.5% |
| Financial debts | 170/4 | €22,226 | €16,341 | -€5,885 | -26.5% |
| Amounts payable within one year | 42/48 | €18,330 | €20,121 | +€1,791 | +9.8% |
| Current portion of amounts payable after more than one year | 42 | €5,654 | €5,885 | +€231 | +4.1% |
| Trade debts | 44 | €1,154 | €1,205 | +€52 | +4.5% |
| Suppliers | 440/4 | €1,154 | €1,205 | +€52 | +4.5% |
| Taxes, remuneration and social security | 45 | €6,803 | €6,471 | -€332 | -4.9% |
| Taxes | 450/3 | €6,803 | €6,471 | -€332 | -4.9% |
| Other amounts payable | 47/48 | €4,720 | €6,560 | +€1,840 | +39.0% |
| Accrued charges and deferred income | 492/3 | €855 | €1,408 | +€553 | +64.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,061 | €6,667 | +€2,607 | +64.2% |
| Other operating charges | 640/8 | - | €120 | +€120 | |
| Gross operating margin | 9900 | €18,464 | €49,163 | +€30,699 | +166% |
| Operating profit (loss) | 9901 | €14,403 | €42,376 | +€27,972 | +194% |
| Financial charges | 65/66B | €489 | €1,086 | +€597 | +122% |
| Recurring financial charges | 65 | €489 | €1,086 | +€597 | +122% |
| Profit (loss) for the period before taxes | 9903 | €13,914 | €41,290 | +€27,376 | +197% |
| Income taxes | 67/77 | €2,871 | €8,513 | +€5,642 | +197% |
| Profit (loss) for the period | 9904 | €11,043 | €32,777 | +€21,734 | +197% |
| Profit (loss) for the period to be appropriated | 9905 | €11,043 | €32,777 | +€21,734 | +197% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.